These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 7344514)

  • 1. Constitutive and carcinogen-derived DNA binding as a basis for the assessment of potency of chemical carcinogens.
    Lutz WK
    Adv Exp Med Biol; 1981; 136 Pt B():1349-65. PubMed ID: 7344514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours.
    Bignold LP
    Carcinogenesis; 2004 Mar; 25(3):299-307. PubMed ID: 14604890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage and repair in mutagenesis and carcinogenesis: implications of structure-activity relationships for cross-species extrapolation.
    Vogel EW; Nivard MJ; Ballering LA; Bartsch H; Barbin A; Nair J; Comendador MA; Sierra LM; Aguirrezabalaga I; Tosal L; Ehrenberg L; Fuchs RP; Janel-Bintz R; Maenhaut-Michel G; Montesano R; Hall J; Kang H; Miele M; Thomale J; Bender K; Engelbergs J; Rajewsky MF
    Mutat Res; 1996 Jun; 353(1-2):177-218. PubMed ID: 8692191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heritable and cancer risks of exposures to anticancer drugs: inter-species comparisons of covalent deoxyribonucleic acid-binding agents.
    Vogel EW; Barbin A; Nivard MJ; Stack HF; Waters MD; Lohman PH
    Mutat Res; 1998 May; 400(1-2):509-40. PubMed ID: 9685708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach.
    Hernández LG; van Steeg H; Luijten M; van Benthem J
    Mutat Res; 2009; 682(2-3):94-109. PubMed ID: 19631282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Background DNA damage for endogenous and unavoidable exogenous carcinogens: a basis for spontaneous cancer incidence?
    Gupta RC; Lutz WK
    Mutat Res; 1999 Mar; 424(1-2):1-8. PubMed ID: 10232953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response relationships in chemical carcinogenesis: superposition of different mechanisms of action, resulting in linear-nonlinear curves, practical thresholds, J-shapes.
    Lutz WK
    Mutat Res; 1998 Sep; 405(2):117-24. PubMed ID: 9748532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of multiple mechanisms of carcinogenesis for short-term testing.
    Harper BL; Morris DL
    Teratog Carcinog Mutagen; 1984; 4(6):483-503. PubMed ID: 6151260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relation between carcinogenesis and mutagenesis: a re-evaluation].
    Bartsch H; Malaveille C
    Bull Acad Natl Med; 1989 Nov; 173(8):1005-12; discussion 1013-5. PubMed ID: 2633853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
    Osimitz TG; Droege W; Boobis AR; Lake BG
    Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of genotoxic carcinogens and non-genotoxic carcinogens.
    Hayashi Y
    Exp Toxicol Pathol; 1992 Dec; 44(8):465-71. PubMed ID: 1493365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis.
    Lutz WK
    Mutat Res; 1979 Dec; 65(4):289-356. PubMed ID: 390383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of genotoxic and carcinogenic action of metals].
    Maksimchuk TP; Babenko GA
    Eksp Onkol; 1990; 12(4):3-9. PubMed ID: 2199186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the risk of tumor occurrence under the effect of small doses of carcinogens.
    Yanysheva NY; Antomonov YG
    Environ Health Perspect; 1976 Feb; 13():95-9. PubMed ID: 1269513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative predictability of carcinogenicity of the covalent binding index of chemicals to DNA: comparison of the in vivo and in vitro assays.
    Taningher M; Saccomanno G; Santi L; Grilli S; Parodi S
    Environ Health Perspect; 1990 Mar; 84():183-92. PubMed ID: 2351121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemically induced cell proliferation in carcinogenesis.
    Butterworth BE; Popp JA; Conolly RB; Goldsworthy TL
    IARC Sci Publ; 1992; (116):279-305. PubMed ID: 1428087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-genotoxic factors in the carcinogenetic process: problems of detection and hazard evaluation.
    Parodi S; Malacarne D; Taningher M
    Toxicol Lett; 1992 Dec; 64-65 Spec No():621-30. PubMed ID: 1471216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.